Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses Hillman Solutions Corp HLMN Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results RELX Q2 2025 Earnings Modest EPS Beat Amid Flat Revenue Disclosure Stock Declines China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment TRINZ Q1 2026 Earnings Slight EPS Beat Amid Cautious Market Reaction TNDM Q1 2026 Earnings Narrowing Losses and Operational Progress Amid Market Headwinds